TickerFacts.

A business in context

ADPT research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-23 · 8022 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-10-19 · 0001780664-26-000043

  2. 4 · Ownership change

    Report date 2026-10-14 · 0001780664-26-000041

  3. 4 · Ownership change

    Report date 2026-10-09 · 0001780664-26-000039

  4. 4 · Ownership change

    Report date 2026-10-06 · 0001820885-26-000025

  5. 4 · Ownership change

    Report date 2026-10-06 · 0001780664-26-000037

  6. 4 · Ownership change

    Report date 2026-10-01 · 0001780664-26-000035

  7. 4 · Ownership change

    Report date 2026-10-01 · 0001780660-26-000024

  8. 4 · Ownership change

    Report date 2026-09-16 · 0001780660-26-000022

  9. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-332940

  10. 8-K · Current report

    Report date 2026-07-24 · 0001193125-26-323753 · Items 2.02,5.02,9.01

  11. 8-K · Current report

    Report date 2026-06-15 · 0001193125-26-277516 · Items 1.01,1.02,2.03,3.02,8.01,9.01

  12. 8-K · Current report

    Report date 2026-06-15 · 0001193125-26-271117 · Items 8.01,9.01

  13. 8-K · Current report

    Report date 2026-06-05 · 0001193125-26-263844 · Items 5.07

  14. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-206546

  15. 8-K · Current report

    Report date 2026-05-05 · 0001193125-26-206455 · Items 2.02,9.01

  16. DEF 14A · Proxy statement

    Report date 2026-06-05 · 0001193125-26-177409

  17. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-076902

  18. 8-K · Current report

    Report date 2026-02-05 · 0001193125-26-039409 · Items 2.02,9.01

  19. 8-K · Current report

    Report date 2026-01-12 · 0001193125-26-009840 · Items 2.02,7.01,9.01

  20. 8-K · Current report

    Report date 2025-12-30 · 0001193125-25-335921 · Items 8.01

  21. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-267061

  22. 8-K · Current report

    Report date 2025-11-05 · 0001193125-25-266974 · Items 2.02,9.01

  23. 8-K · Current report

    Report date 2025-08-13 · 0001193125-25-182222 · Items 1.02

  24. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-103120

  25. 8-K · Current report

    Report date 2025-08-05 · 0000950170-25-103058 · Items 2.02,9.01

  26. 8-K · Current report

    Report date 2025-06-10 · 0001193125-25-140017 · Items 5.07

  27. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-061897

  28. 8-K · Current report

    Report date 2025-05-01 · 0000950170-25-061851 · Items 2.02,9.01

  29. DEF 14A · Proxy statement

    Report date 2025-06-10 · 0001193125-25-103752

  30. 10-K · Annual report

    Report date 2024-12-31 · 0000950170-25-030913

  31. 8-K · Current report

    Report date 2025-02-11 · 0000950170-25-017915 · Items 2.02,9.01

  32. SC 13G · Ownership disclosure

    0001104659-24-117737

  33. SC 13G/A · Ownership disclosure

    0000902664-24-006448

  34. SC 13G/A · Ownership disclosure

    0000932471-24-000885

  35. SC 13G · Ownership disclosure

    0001140361-24-045810

  36. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000950170-24-123423

  37. 8-K · Current report

    Report date 2024-11-07 · 0000950170-24-123369 · Items 2.02,9.01

  38. SC 13G · Ownership disclosure

    0001214659-24-018424

  39. SC 13G · Ownership disclosure

    0000932471-24-000260

  40. SC 13G/A · Ownership disclosure

    0001319244-24-000051

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-23 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 25 transaction rows25SGrant / award: 0 transaction rows0AExercise / conversion: 40 transaction rows40MTax / exercise payment: 0 transaction rows0FGift: 1 transaction rows1G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

66 matching transaction rows. Showing 51 to 66.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-07-02
2026-07-06
LO FRANCIS
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (right to buy)
Derivative security
12600.00.0
2026-07-02
2026-07-06
LO FRANCIS
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (right to buy)
Derivative security
12626.00.0
2026-07-02
2026-07-06
LO FRANCIS
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (right to buy)
Derivative security
12637.00.0
2026-07-01
2026-07-06
BOBULSKY SUSAN
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock487.022.0
2026-07-01
2026-07-06
LO FRANCIS
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock3300.012.14
2026-07-01
2026-07-06
LO FRANCIS
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock3500.07.8
2026-07-01
2026-07-06
LO FRANCIS
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock12206.08.46
2026-07-01
2026-07-06
LO FRANCIS
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock4688.03.99
2026-07-01
2026-07-06
LO FRANCIS
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock14064.08.12
2026-07-01
2026-07-06
LO FRANCIS
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock8743.022.18
2026-07-01
2026-07-06
LO FRANCIS
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock42261.022.5
2026-07-01
2026-07-06
LO FRANCIS
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (right to buy)
Derivative security
12206.00.0
2026-07-01
2026-07-06
LO FRANCIS
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (right to buy)
Derivative security
3300.00.0
2026-07-01
2026-07-06
LO FRANCIS
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (right to buy)
Derivative security
3500.00.0
2026-07-01
2026-07-06
LO FRANCIS
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (right to buy)
Derivative security
4688.00.0
2026-07-01
2026-07-06
LO FRANCIS
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (right to buy)
Derivative security
14064.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-23 · 1658 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001478320Adaptive Biotechnologies Corp

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-23 · 1197 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Adaptive Biotechnologies · alias · wikidata
  • Adaptive TCR Corp · former SEC name · 2009-12-28 to 2011-06-02
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$178.96M$192.22M
2023-12-31$170.28M$188.28M
2022-12-31$185.31M$213.31M
2021-12-31$154.34M$191.89M
2020-12-31$98.38M$128.08M
2019-12-31$85.07M$112.11M
2018-12-31$55.66M$74.69M
2017-12-31$38.45M$52.85M

Bureau of Labor Statistics · retrieved 2026-10-23 · 9 selected series; gaps remain missing

Explore the CPI history ↗